Researchanalyst
23.02.2023, Author: André Will-Laudien

The comeback of the chemical giant

An important component of the global effort to protect the climate is clean energy generation and storage. Efficient electricity use requires high-performance storage systems that allow energy to be used regardless of the time of day. The chemical industry has been working for decades on processes that enable more efficient exploitation of our resources. For the chemical giant BASF from Ludwigsburg, Germany is not an easy terrain for innovative research and development due to its high-cost structure. We provide an update from Ludwigshafen.

Read the report


22.02.2023, Author: Nico Popp

Partnership with world-class cancer clinic City of Hope

The renowned City of Hope Clinic in the greater Los Angeles area wants nothing less than to lead the revolution in the fight against cancer. Here, where globally acclaimed breakthroughs against blood cancer and diabetes were achieved in the 1970s, the biotech company Defence Therapeutics now wants to clear important hurdles in the approval process of the US Food and Drug Administration (FDA). Here is what the collaboration is all about and what it could mean for the young biotech company.

Read the report


21.02.2023, Author: André Will-Laudien

Highest net profit since 2007

The major interest rate turnaround in 2022 is bringing the big banks back into business. While banks had to contend with negative interest rates during the period of low-interest rates, the situation is now increasingly easing. The deposit side is generating positive inflows, and the lending business is again generating adequate margins. Deutsche Bank is back at the level of 2007, i.e. shortly before the outbreak of the financial crisis. Its transformation into the modern age would be largely complete if it were not for the threat of insolvencies generated by the aftermath of the Corona pandemic hanging over the lending business as a sword of Damocles. We provide an update from Frankfurt.

Read the report


20.02.2023, Author: Stefan Feulner

Growth targets remain despite misses

It is well known that hydrogen is a central building block for the energy transition and achieving climate targets. With the launch of programs worth billions of dollars, not only the USA with the Inflation Reduction Act and China with announced subsidies of around USD 280 billion, but also Europe wants to make huge investments in the green energy of the future. One of the most important players in this field is the pioneer of fuel cell technology, Plug Power. The Company plans to build an end-to-end ecosystem for green hydrogen, ranging from production, distribution, storage and delivery to power generation, in order to benefit from the enormous economies of scale. However, there is a big gap between the ambitious plans and the implementation.

Read the report


14.02.2023, Author: Stefan Feulner

Battle for supremacy in the hydrogen sector

To ensure the competitiveness of their countries in the field of green energies, politicians are outbidding each other with subsidy programs in the triple-digit billions. Last year, the US already came up with the "Inflation Reduction Act" in the amount of USD 370 billion, on the one hand, to promote domestic industry and, on the other hand, to lure foreign corporations overseas. The EU is challenged to maintain the connection because, besides the United States, China has also announced subsidies in green technologies of more than USD 280 billion. The European Union now wants to counter with the "Green Deal Industrial Plan" in order to secure Europe as a business location in the long term. One of the main beneficiaries of this bid is the global hydrogen innovator First Hydrogen, which, in addition to branches in North America, Great Britain and Europe, is also likely to profit several times over with the development of light commercial vehicles, refueling systems and the production and distribution of green hydrogen.

Read the report


10.02.2023, Author: Juliane Zielonka

A chemical engineer from the US takes over the leadership in Leverkusen

Shareholders of the agrochemicals and pharmaceuticals group Bayer made an unprecedented decision at the 2019 Annual Stockholders' Meeting: Werner Baumann, the incumbent Dax boss, was the first not to be discharged. Now - after four out of five years of his current contract - the way is clear for an external manager. Bill Anderson takes the helm as of April 1. Find out how the surprising change came about a year earlier than expected and what the consequences are for investors in this stock update.

Read the report


09.02.2023, Author: Stefan Feulner

Buyback program and outlook inspire

After the chaotic year 2021, with several forecast reductions and a decline of the TeamViewer share of around 80%, the past fiscal year was characterized by consolidation, both in the operating business and on the stock exchange. By achieving its annual targets, the MDAX-listed company partially regained the confidence of investors and analysts. With a positive outlook, TeamViewer expects double-digit revenue growth within a range of 10% to 14% for fiscal year 2023. With stable profitability, the long-term rebound could gain further momentum. The planned exit from the horrendous shirt sponsorship deal with Manchester United should provide a significant positive effect.

Read the report


07.02.2023, Author: Stefan Feulner

Expansion into further countries planned

The ramp-up of electromobility continued in 2022. Despite delays due to blown supply chains and plant closures caused by Corona lockdowns, sales of pure battery-powered vehicles increased by around 63% to 7 million. Globally, US manufacturer Tesla still holds the most market share, with 1.3 million units sold. In China, however, the world's largest market, the company of the controversial leader Elon Musk was already knocked off its throne in the first half of the year by the Chinese technology company BYD. Since then, the Warren Buffett-backed group has continued to expand its lead and is likely to come closer to its global place in the sun by expanding into other countries.

Read the report


06.02.2023, Author: Nico Popp

Nasal spray for lung cancer? Numerous clinical studies ahead

Scientific findings gain significance when validated and discussed by independent researchers. Defence Therapeutics' technology recently received funding and expert endorsement from Canadian biotech funder CQDM, which is funded by numerous industry multinationals, among others. We look at what the collaboration could mean for Defence Therapeutics, why nasal spray as chemotherapy is increasingly likely, and why Defence's technology portfolio fits the bill right now in what analysts expect to be a wave of acquisitions in the biotech sector.

Read the report


03.02.2023, Author: André Will-Laudien

H2 - The stuff dreams are made of

The war in Ukraine exacerbates the need for the measures adopted in recent years to change our energy supply. The sudden scarcity and accompanying price explosion of fossil fuels is driven by our dependence on Russia and China alone in the European renewal process. Experts now realise that electromobility will probably only have a positive impact on the ambient air. Other concepts must be put on the table! When it comes to hydrogen, the EU can be said to be a global pioneer in hydrogen technology, despite much lip service. Nel ASA is a Scandinavian protagonist with high innovative power. An update from Norway.

Read the report